|
| 产地 | 中国 |
| 品牌 | Chemstan |
| 货号 | LC-01 |
| 用途 | 中间体 |
| 包装规格 | 20mg |
| 纯度 | 98%% |
| CAS编号 | 1262036-50-9 |
| 是否进口 | 否 |
联合知名大学科研院所及企业开发药食两用植物标准品和天然植物有效单体，主打中药对照品/标准品/天然植物有效单体，小分子化合物库，药物杂质。所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。
Fields of Application :
LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.
| CAS Number: | 1262036-50-9 |
| Purity: | >98% |
| Molecular Weight: | 390.41 |
| Molecular Formula: | C18H16F2N4O2S |
Quality Control: HPLC、NMR、 LC/MS(Please contact us to get the QC report)
| Synonyms: | LY 2886721,LY-2886721,N-(3-((4aS,7aS)-2-amino-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-7a-yl)-4-fluorophenyl)-5-fluoropicolinamide |
| Chemical Name: | |
| Storage: | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
Note: Products for research use only, not for human use
Description:
LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease. IC50 value: Target: BACE LY2886721 is a novel potent agent that is used to treat Alzheimer’s Disease in preclinical experiments. LY2886721 is under clinical study. A Safety Study of LY2886721 Multiple Doses is performing in Healthy Subjects.For the detailed information of LY2886721, the solubility of LY2886721 in water, the solubility of LY2886721 in DMSO, the solubility of LY2886721 in PBS buffer, the animal experiment (test) of LY2886721, the cell expriment (test) of LY2886721, the in vivo, in vitro and clinical trial test of LY2886721, the EC50, IC50,and Affinity of LY2886721.
References:
C1[C@H]2CSC(=N[C@]2(CO1)C3=C(C=CC(=C3)NC(=O)C4=NC=C(C=C4)F)F)N
